Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
NCT02921672 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-02-06
Summary
By doing this study, researchers hope to learn if older adults with and without cognitive impairment can adhere to a Mediterranean diet.
Conditions
Interventions
- OTHER
-
Mediterranean Diet
Diet consisting of fruits, vegetables, grains, dairy, olive oils, seafood, and nuts. It is low in red meat and solid fats.
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Deborah K Sullivan, PhD, RD, LD · University of Kansas Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-06-22
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial of a Low Protein Diet in Patients With Cognitive Impairment
NCT05480358 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Metformin in Alzheimer's Dementia Prevention
NCT04098666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
NCT01466270 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Multicultural Healthy Diet to Reduce Cognitive Decline
NCT03240406 ·Status: COMPLETED ·Phase: NA
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
NCT01702480 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Pomegranate Seed Oil and Mediterranean Diet on MCI
NCT04990362 ·Status: UNKNOWN ·Phase: NA
-
Effects of a Nutraceutic Compound on Cognitive Impairment
NCT06200883 ·Status: COMPLETED ·Phase: PHASE4
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
Ageing Gut Brain Interactions
NCT03593941 ·Status: COMPLETED
-
CPC-201 Alzheimer's Disease Type Dementia: PET Study
NCT02860065 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Ketogenic Diet for Alzheimer's Disease
NCT04701957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
NCT00293176 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
NCT02822573 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
NCT02695004 ·Status: COMPLETED ·Phase: PHASE1
-
The Ketogenic Diet in the Treatment of Alzheimer's Disease
NCT06681948 ·Status: COMPLETED ·Phase: NA
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 ·Status: RECRUITING ·Phase: NA
-
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
NCT03316898 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2